During the past decade, The Polyclinic conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 29 clinical trials were completed, i.e. on average, 241.7% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 11 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "The Polyclinic" #1 sponsor was "National Cancer Institute (NCI)" with 15 trials, followed by "Celgene" with 4 trials sponsored, "Allergan" with 3 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored and "SWOG Cancer Research Network" with 3 trials sponsored. Other sponsors include 5 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Polyclinic" #1 collaborator was "National Cancer Institute (NCI)" with 5 trials as a collaborator, "Eastern Cooperative Oncology Group" with 2 trials as a collaborator, "Arkana Labs" with 1 trials as a collaborator, "Cancer and Leukemia Group B" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "The Polyclinic" are "Adenocarcinoma of the Gastroesophageal Junction" (2 trials), "Atrial Fibrillation" (2 trials), "Diabetes Mellitus, Type 2" (2 trials), "Multiple Sclerosis" (2 trials) and "Recurrent Melanoma" (2 trials). Many other conditions were trialed in "The Polyclinic" in a lesser frequency.

Most popular intervention types in "The Polyclinic" are "Drug" (35 trials), "Biological" (9 trials), "Other" (8 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (8 trials), "fluorouracil" (5 trials), "leucovorin calcium" (4 trials), "Bevacizumab" (3 trials) and "Laboratory Biomarker Analysis" (3 trials). Other intervention names were less common.

The vast majority of trials in "The Polyclinic" are 37 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "The Polyclinic". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 26 completed trials in The Polyclinic, 1 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in The Polyclinic, 1 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 20 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".